Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling
Authors:
- 15 July 2017
- book chapter
- Published by Springer Nature
- Vol. 414, 159-192
Abstract
In the tumor microenvironment, cancer cells encounter both external and internal factors that can lead to the accumulation of improperly folded proteins in the Endoplasmic Reticulum (ER) lumen, thus causing ER stress. When this happens, an adaptive mechanism named the Unfolded Protein Response (UPR) is triggered to help the cell cope with this change and restore protein homeostasis in the ER. Sequentially, one would expect that the activation of the three UPR branches, driven namely by IRE1, PERK, and ATF6, are crucial for the adaptation of cancer cells to the changing environment and thus for their survival and further propagation. Indeed, in the last few years, an increasing amount of studies has shown the implication of UPR signaling in different aspects of carcinogenesis and tumor progression. Features such as sustaining proliferation and resistance to cell death, genomic instability, altered metabolism, increased inflammation and tumor-immune infiltration, invasion and metastasis, and angiogenesis, defined as “the hallmarks of cancer”, can be regulated by the UPR machinery. At the same time, new potential therapeutic interventions applicable to different kinds of cancers are being revealed. In order to describe the emerging role of UPR in cancer biology, these are the points that will be discussed in this chapter.Keywords
This publication has 196 references indexed in Scilit:
- Pharmacological brake-release of mRNA translation enhances cognitive memoryeLife, 2013
- Proteostasis Modulators Prolong Missense VHL Protein Activity and Halt Tumor ProgressionCell Reports, 2013
- IRE1α controls cyclin A1 expression and promotes cell proliferation through XBP-1Cell Stress and Chaperones, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- HIV protease inhibitor lopinavir-induced TNF-α and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophagesBiochemical Pharmacology, 2009
- XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel DiseaseCell, 2008
- The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma PathogenesisCancer Cell, 2007
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- A Novel Mechanism for Regulating Activity of a Transcription Factor That Controls the Unfolded Protein ResponseCell, 1996
- A transmembrane protein with a cdc2+CDC28-related kinase activity is required for signaling from the ER to the nucleusCell, 1993